 |
|
|
| |
The in vitro cross-resistance profile of the NRTI
BMS-986001 against known NRTI resistance mutations
|
| |
| |
Reported by Jules Levin
International Workshop on HIV and Hepatitis Virus Drug Resistance
5-9 June 2012, Sitges, Spain
Zhufang Li,1 Brian Terry,1 William Olds,1 Tricia Protack,1 Carol Deminie,1
Beatrice Minassian,1 Beata Nowicka-Sans,1 Ira Dicker,1 Carey Hwang,2 Max Lataillade,1 George J Hanna3 and Mark Krystal1
1Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA
2Bristol-Myers Squibb, Research and Development, Hopewell, NJ, USA
3Bristol-Myers Squibb, Research and Development, Princeton, NJ, USA
|
| |
|
|
|
|
|
